Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 2 |
2020 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors.
Int J Mol Sci. 2020 Oct 9;21(20):7449. doi: 10.3390/ijms21207449.
Int J Mol Sci. 2020.
PMID: 33050329
Free PMC article.
Review.
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness.
Farrera-Sal M, de Sostoa J, Nuñez-Manchón E, Moreno R, Fillat C, Bazan-Peregrino M, Alemany R.
Farrera-Sal M, et al. Among authors: de sostoa j.
Int J Mol Sci. 2020 Jul 21;21(14):5158. doi: 10.3390/ijms21145158.
Int J Mol Sci. 2020.
PMID: 32708234
Free PMC article.
Item in Clipboard
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
de Sostoa J, Fajardo CA, Moreno R, Ramos MD, Farrera-Sal M, Alemany R.
de Sostoa J, et al.
J Immunother Cancer. 2019 Jan 25;7(1):19. doi: 10.1186/s40425-019-0505-4.
J Immunother Cancer. 2019.
PMID: 30683154
Free PMC article.
Item in Clipboard
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy.
Fajardo CA, Guedan S, Rojas LA, Moreno R, Arias-Badia M, de Sostoa J, June CH, Alemany R.
Fajardo CA, et al. Among authors: de sostoa j.
Cancer Res. 2017 Apr 15;77(8):2052-2063. doi: 10.1158/0008-5472.CAN-16-1708. Epub 2017 Jan 31.
Cancer Res. 2017.
PMID: 28143835
Item in Clipboard
Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers.
Barlabé P, Sostoa J, Fajardo CA, Alemany R, Moreno R.
Barlabé P, et al. Among authors: sostoa j.
Cancer Gene Ther. 2020 May;27(5):383-388. doi: 10.1038/s41417-019-0110-1. Epub 2019 Jun 17.
Cancer Gene Ther. 2020.
PMID: 31204390
Item in Clipboard
Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus.
Al-Zaher AA, Moreno R, Fajardo CA, Arias-Badia M, Farrera M, de Sostoa J, Rojas LA, Alemany R.
Al-Zaher AA, et al. Among authors: de sostoa j.
Mol Ther Oncolytics. 2018 Jan 31;8:62-70. doi: 10.1016/j.omto.2018.01.003. eCollection 2018 Mar 30.
Mol Ther Oncolytics. 2018.
PMID: 29888319
Free PMC article.
Item in Clipboard
Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression.
da Silva-Diz V, Simón-Extremera P, Bernat-Peguera A, de Sostoa J, Urpí M, Penín RM, Sidelnikova DP, Bermejo O, Viñals JM, Rodolosse A, González-Suárez E, Moruno AG, Pujana MÁ, Esteller M, Villanueva A, Viñals F, Muñoz P.
da Silva-Diz V, et al. Among authors: de sostoa j.
Cancer Res. 2016 Mar 1;76(5):1245-59. doi: 10.1158/0008-5472.CAN-15-1631. Epub 2015 Dec 30.
Cancer Res. 2016.
PMID: 26719534
Item in Clipboard
Cite
Cite